Certara, Inc. Profile Avatar - Palmy Investing

Certara, Inc.

Certara, Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation s…
Medical - Healthcare Information Services
US, Princeton [HQ]

Balance Sheet

6 Sheets · Starting from 2023
In Million USD. Margins, Growth Rates In %
Metric 2018 2019 2020 2021 2022 2023
Assets
1,051.00 1,037.00 1,269.00 1,511.00 1,572.00 1,563.00
Current
68.00 87.00 346.00 274.00 342.00 340.00
Non Current
982.00 949.00 922.00 1,237.00 1,230.00 1,222.00
Liabilities
558.00 545.00 447.00 469.00 493.00 516.00
Current
65.00 63.00 75.00 92.00 103.00 130.00
Non Current
493.00 482.00 371.00 377.00 390.00 386.00
Equity
492.00 492.00 822.00 1,041.00 1,079.00 1,046.00
Stockholders' Equity
492.00 492.00 822.00 1,041.00 1,079.00 1,046.00
Retained Earnings
-14.00 -12.00 -62.00 -75.00 -60.00 -116.00
Common Stock
1.00 1.00 1.00 1.00 1.00 1.00
Preferred Stock
- - - - - - - - - - - -
Profit
-33.00 -8.00 -49.00 -13.00 14.00 -55.00
Dividends
- - - - - - - - - - - -
Minority Interest
- - - - - - - - - - - -
Other Stockholders' Equity
507.00 509.00 884.00 1,119.00 1,147.00 1,169.00
Loss Other Compr. Income
-1.00 -5.00 -1.00 -3.00 -8.00 -7.00
End of CERT's Analysis
CIK: 1827090 CUSIP: 15687V109 ISIN: US15687V1098 LEI: - UEI: -
Secondary Listings
CERT has no secondary listings inside our databases.